Sun-Novo Pharma Gains NMPA Approval for STC007 Clinical Study in CKD-aP
China-based Beijing Sun-Novo Pharmaceutical Research Co., Ltd (SHA: 688621) has announced receiving approval from the...
JD Healthcare Partners with Jiangsu Yuyue for Medical Device Collaboration
JD Healthcare, a unit of China’s e-commerce giant JD.com (NASDAQ: JD), has announced a partnership...
Junshi Biosciences’ JunMaiKang Approved by NMPA for Multiple Indications
China-based Junshi Biosciences (HKG: 1877, SHA: 688180) has announced that its JunMaiKang, a biosimilar version...
Hengrui Pharmaceuticals Receives FDA ANDA Approval for Gadobutrol Generic
China-based Jiangsu Hengrui Pharmaceuticals (SHA: 600276) has announced receiving Abbreviated New Drug Application (ANDA) status...
Fosun Pharma’s Bivalent COVID-19 Vaccine Comirnaty Authorized in Hong Kong
Shanghai Fosun Pharmaceutical Group Co (SHA: 600196) has announced obtaining emergency use authorization (EUA) in...
IASO Biotherapeutics Reports Positive Phase I Results for CAR-T Therapy in NMOSD
China-based IASO Biotherapeutics has announced the interim results of a Phase I investigator-initiated-trial (ITT) for...
ViVest Medical Raises Funds for Wearable Cardioverter Defibrillator Development
Suzhou-based device maker ViVest Medical Technology Co., Ltd has reportedly raised “hundreds of millions” of...
Mabwell Receives Approval for Clinical Study of 9MW3011 in Polycythemia Vera
China-based Mabwell (Shanghai) Bioscience Co., Ltd (SHA: 688062) has announced receiving approval to conduct a...
China’s CDE, HNMPA, and Bo’ao Lecheng Release Real-world Drug Research Measures
The Center for Drug Evaluation (CDE), Hainan Medical Products Administration (HNMPA), and Bo’Ao Lecheng Medical...
Hotgen Biotech Receives FDA EUA for COVID-19 Antigen Home Test
China-based Hotgen Biotech Co., Ltd (SHA: 688068) has announced receiving Emergency Use Authorization (EUA) from...
Wolters Kluwer Partners with China’s NCID to Advance Infectious Disease Diagnosis
Holland-based information and software solutions provider Wolters Kluwer has announced a partnership with China’s National...
Jiangxi Healthcare Security Administration Launches New VBP Tender
The Jiangxi Healthcare Security Administration (JHSA) has released a notice of a new volume-based procurement...
Fapon Biotech Partners with CR Pharma to Develop IVD Open Platform Ecosystem
China-based biotech Fapon Biotech Inc. has announced a partnership with China Resources Pharmaceutical Commercial Group...
Henlius’ Serplulimab Phase III Study Approved in Spain for LS-SCLC
China-based Shanghai Henlius Biotech (HKG: 2696) has announced that its global, multi-center Phase III clinical...
Hainan Poly Pharm Wins Finland Approval for Generic Cytovene-IV
China-based Hainan Poly Pharm Co., Ltd (SHE: 300630) has announced receiving marketing approval from the...
Kangtai Biological Completes Phase III Clinical Data Analysis for COVID-19 Vaccine
China-based Shenzhen Kangtai Biological Products Co., Ltd (SHE: 300601) has announced the completion of the...
Jiangxi Leads 22-Province Alliance in VBP for Liver Function Test Reagents
The provincial drug and medical consumables centralized procurement joint meeting office of Jiangxi has released...
Fapon Biotech Partners with Roche Diagnostics at China International Import Expo
China-based biotech Fapon Biotech Inc. has announced a partnership with Swiss major Roche Diagnostics at...
China’s Jiangsu Bioda Gains NMPA Approval for Innovative Artificial Blood Vessel
The National Medical Products Administration (NMPA) has granted marketing approval to China-based Jiangsu Bioda Life...
Visen Pharmaceuticals Publishes Phase III Data for Lonapegsomatropin in Growth Hormone Deficiency
Visen Pharmaceuticals, a China-based joint venture between Denmark-headquartered Ascendis Pharma and Chinese healthcare-focused investment firm...